Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -0.29% | -6.79% | +106.63% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 77.71M | Sales 2025 * | 92.23M | Capitalization | 330M |
---|---|---|---|---|---|
Net income 2024 * | -179M | Net income 2025 * | -172M | EV / Sales 2024 * | 2.57 x |
Net cash position 2024 * | 130M | Net cash position 2025 * | 88.83M | EV / Sales 2025 * | 2.62 x |
P/E ratio 2024 * |
-1.82
x | P/E ratio 2025 * |
-2.17
x | Employees | 274 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.36% |
Latest transcript on ADC Therapeutics SA
1 day | -0.29% | ||
1 week | -6.79% | ||
1 month | -27.18% | ||
3 months | -29.42% | ||
6 months | +209.01% | ||
Current year | +106.63% |
Managers | Title | Age | Since |
---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 51 | 22-05-08 |
Jose Carmona
DFI | Director of Finance/CFO | 51 | 22-12-18 |
Mohamed Zaki
CTO | Chief Tech/Sci/R&D Officer | 59 | 23-01-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Hug
BRD | Director/Board Member | 65 | 19-05-31 |
Ron Squarer
CHM | Chairman | 57 | 20-03-31 |
Jean Bizzari
BRD | Director/Board Member | 69 | 22-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 3.43 | -0.29% | 778,211 |
24-05-30 | 3.44 | +3.30% | 616,606 |
24-05-29 | 3.33 | -6.72% | 528,929 |
24-05-28 | 3.57 | -2.99% | 837,060 |
24-05-24 | 3.68 | +1.10% | 378,838 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+106.63% | 330M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ADCT Stock